#45 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
Clinicians treating veterans and military-age patients should understand that relaxed cannabis restrictions may increase use prevalence in this population, requiring updated substance use screening and counseling protocols. This policy change could affect pain management discussions with military personnel, as some may substitute cannabis for opioids or other prescribed treatments, necessitating evidence-based guidance on efficacy and drug interactions. Veterans with PTSD or chronic pain may now more openly disclose cannabis use to providers, enabling clinicians to better assess harms, benefits, and integration with existing treatment plans.
The U.S. Army has raised the maximum enlistment age to 42 and relaxed its marijuana policies to allow recruits with prior cannabis use to enlist with a waiver, representing a significant shift in military recruitment standards. This policy change reflects broader evolving social and legal perspectives on cannabis use, particularly as more states legalize the substance and younger populations report higher lifetime exposure to marijuana. For clinicians, this policy has implications for veteran patient populations, as military service members and veterans may now include individuals with documented cannabis use histories, which could affect clinical assessment of substance use patterns and underlying reasons for military service decisions. The easing of restrictions may also influence how veterans disclose or discuss cannabis use with their healthcare providers, potentially improving transparency in clinical settings where veterans seek care for service-related conditions. Clinicians should be aware that this policy change may alter the demographic characteristics of veteran patients they serve and should maintain nonjudgmental assessment practices when discussing cannabis use history with military service members and veterans. Understanding these policy shifts helps clinicians better contextualize patient backgrounds and provide more informed, stigma-free care to veteran populations seeking treatment.
“The Army’s decision to waive prior marijuana use for enlistment reflects what we’ve been seeing in clinical practice for years now: cannabis use, particularly in younger adults, no longer predicts functional impairment or unsuitability for demanding roles, and arbitrary exclusions based on historical stigma actually cost us qualified personnel who could benefit from structured employment and purpose.”
🪖 The U.S. Army’s decision to ease marijuana restrictions and raise the enlistment age cap reflects evolving workforce needs and changing social norms around cannabis use, but presents clinical considerations for providers caring for service members and veterans. While relaxed screening policies may increase recruitment from a broader demographic pool, clinicians should recognize that cannabis use during military service may complicate occupational health assessments, cognitive and motor skill evaluations, and mental health screening—particularly given cannabis’s potential effects on reaction time, decision-making, and long-term neurocognitive outcomes. The shift also raises questions about standardization of documentation and disclosure across military and civilian healthcare settings, since service members may have incomplete or inconsistent records regarding their cannabis use history and timing relative to enlistment. Additionally, providers should consider that older recruits (up to age 42) may have different patterns of cannabis use, comorbid medical conditions, and medication interactions compared to traditional younger
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it: